IL10 and myocardial infarction: Nevertheless, and to avoid possible antibody-induced immunogenicity responses, we designed lipid nanoparticles (NIL10) conjugated with IT9302 [25], a nanomeric peptide, homologous to the C terminus of IL-10, or a scramble peptide (NIL10SC) as a negative control, to evaluate its contribution to the resolution of inflammation following acute myocardial infarction in mice and pigs